CD4 Assessment in Newly Diagnosed HIV-Infected Pregnant Women in India's PPTCT Programme
This study evaluates the significance of CD4 cell count assessment among newly diagnosed HIV-infected pregnant women participating in India's National Prevention of Parent to Child Transmission (PPTCT) Programme. It highlights the importance of timely CD4 testing and the implications of adopting a 'Test and Treat' approach for effective management of HIV in pregnancy. The findings shed light on current practices, policy implications, and the need for improved access to antiretroviral therapy to enhance maternal and child health outcomes.
CD4 Assessment in Newly Diagnosed HIV-Infected Pregnant Women in India's PPTCT Programme
E N D
Presentation Transcript
CD4 assessment among newly diagnosed HIV-infected pregnant women in India’s National Prevention of Parent to Child Transmission Programme (PPTCT)Implications for a ‘Test and Treat’ Approach S. K. Mohammed1 R.S. Gupta2 R. Rao2 V. Joseph2 P. Srikantiah3 1Reproductive and Child Health Division, Ministry of Health and Family Welfare, New Delhi, India 2National AIDS Control Organisation, Ministry of Health and Family Welfare, New Delhi, India 3HIV/AIDS Division, San Francisco General Hospital, UCSF, San Francisco, USA
PPTCT Programmein India Pregnant Women Who Receive Antenatal HIV Testing, 2001-2011 Number Pregnant Women Tested
PPTCT Guidelines -India, 2010 HIV+ pregnant woman detected Specimen transport for those who cannot travel Referred for HIV clinical assessment and CD4 testing at nearest ART centre CD4 < 350 CD4 > 350 Lifelong ART sd-NVP